Home > > > > > Report Detail

Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials

Publisher Name :
Date: 01-Oct-2018
No. of pages: 500
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies

Global Cardiovascular Partnering 2012 to 2018 provides the full collection of Cardiovascular disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

Trends in Cardiovascular partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Cardiovascular partnering agreement structure

Cardiovascular partnering contract documents

Top Cardiovascular deals by value

Most active Cardiovascular dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Cardiovascular disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Cardiovascular deals.

The report presents financial deal terms values for Cardiovascular deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Cardiovascular dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Cardiovascular dealmaking since 2012 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Cardiovascular deals since 2012. Deals are listed by headline value. The chapter includes the top 25 most active Cardiovascular dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Cardiovascular deals since 2012 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Cardiovascular partnering deals by specific Cardiovascular target announced since 2012. The chapter is organized by specific Cardiovascular therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Cardiovascular partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Cardiovascular partnering and dealmaking since 2012.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Cardiovascular technologies and products.

Report scope

Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials is intended to provide the reader with an in-depth understanding and access to cardiovascular trends and structure of deals entered into by leading companies worldwide.

Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials includes:

Trends in cardiovascular dealmaking in the biopharma industry since 2012

Analysis of cardiovascular deal structure

Access to headline, upfront, milestone and royalty data

Access to over 1,000 cardiovascular deal records

The leading cardiovascular deals by value since 2012

The report includes deals for the following indications: Abdominal aortic aneurysm, Angina, Arrhythmia, Atrial fibrillation, Long QT syndrome, Supraventricular Tachycardia, Ventricular fibrillation, Ventricular tachycardia, Atherosclerosis, Breathlessness, Cardiogenic shock, Cardiomyopathy (heart muscle disease), Chest pain, Congenital heart disease, Congestive heart failure, Coronary artery disease, Ductus arteriosus, Fatigue, Hypercholesterolemia, Hypertension, Intermittent claudication, Ischemic heart disease, Limb ischemia, Marfan's Syndrome, Myocardial Infarction, Oedema (excess fluid), Palpitations, Peripheral arterial disease, Thrombus (blood clot), Valvular heart disease, Aortic stenosis, Restenosis, Varicose veins, plus other cardiovascular indications.

In Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials, the available deals are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials report provides comprehensive access to available deals and contract documents for over 1,000 cardiovascular deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Benefits

Global Cardiovascular Partnering 2012 to 2018 provides the reader with the following key benefits:

In-depth understanding of Cardiovascular deal trends since 2012

Access Cardiovascular deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between Cardiovascular partner companies

Comprehensive access to over 750 links to actual Cardiovascular deals entered into by the world's biopharma companies

Indepth review of Cardiovascular deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner Cardiovascular opportunities

Uncover companies actively partnering Cardiovascular opportunities

Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Cardiovascular dealmaking
2.1. Introduction
2.2. Cardiovascular partnering over the years
2.3. Cardiovascular partnering by deal type
2.4. Cardiovascular partnering by industry sector
2.5. Cardiovascular partnering by stage of development
2.6. Cardiovascular partnering by technology type
2.7. Cardiovascular partnering by therapeutic indication

Chapter 3 -Financial deal terms for Cardiovascular partnering
3.1. Introduction
3.2. Disclosed financials terms for Cardiovascular partnering
3.3. Cardiovascular partnering headline values
3.4. Cardiovascular deal upfront payments
3.5. Cardiovascular deal milestone payments
3.6. Cardiovascular royalty rates

Chapter 4 - Leading Cardiovascular deals and dealmakers
4.1. Introduction
4.2. Most active in Cardiovascular partnering
4.3. List of most active dealmakers in Cardiovascular
4.4. Top Cardiovascular deals by value

Chapter 5 - Cardiovascular contract document directory
5.1. Introduction
5.2. Cardiovascular partnering deals where contract document available

Chapter 6 - Cardiovascular dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Cardiovascular therapeutic target

Appendices
Appendix 1 - Directory of Cardiovascular deals by company A-Z 2012 to 2018
Appendix 2 - Directory of Cardiovascular deals by deal type 2012 to 2018
Appendix 3 - Directory of Cardiovascular deals by stage of development 2012 to 2018
Appendix 4 - Directory of Cardiovascular deals by technology type 2012 to 2018
Further reading on dealmaking
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

List of Tables and Figures

Figure 1: Cardiovascular partnering since 2012
Figure 2: Cardiovascular partnering by deal type since 2012
Figure 3: Cardiovascular partnering by industry sector since 2012
Figure 4: Cardiovascular partnering by stage of development since 2012
Figure 5: Cardiovascular partnering by technology type since 2012
Figure 6: Cardiovascular partnering by indication since 2012
Figure 7: Cardiovascular deals with a headline value
Figure 8: Cardiovascular deals with upfront payment values
Figure 9: Cardiovascular deals with milestone payment
Figure 10: Cardiovascular deals with royalty rates
Figure 11: Active Cardiovascular dealmaking activity- 2012 to 2018
Figure 12: Top Cardiovascular deals by value since 2012
  • Global Thoracic Surgery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Thoracic Surgery market: According to our latest research, the global Thoracic Surgery market looks promising in the next 5 years. As of 2022, the global Thoracic Surgery market was estimated at USD 3777.06 million, and it's anticipated to reach USD 4689.46 million in 2028, with a CAGR of 3.67% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Thoracic Su......
  • Global Angina Pectoris Treatment Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 125
    Report Overview: The Global Angina Pectoris Treatment Market Size was estimated at USD 8809.40 million in 2022 and is projected to reach USD 9981.15 million by 2029, exhibiting a CAGR of 1.80% during the forecast period. This report provides a deep insight into the global Angina Pectoris Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......
  • Global Dilated Cardiomyopathy Therapeutics Market Status and Outlook 2023-2028
    Published: 22-Nov-2023        Price: US 3160 Onwards        Pages: 100
     Dilated cardiomyopathy is currently defined by the presence of left ventricular (LV) or biventricular dilatation and systolic dysfunction in the absence of abnormal loading conditions (hypertension, valve disease) or coronary artery disease sufficient to cause global systolic impairment. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for ea......
  • Global Transcatheter Mitral Valve Replacement Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Sep-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Transcatheter Mitral Valve Replacement market: According to our latest research, the global Transcatheter Mitral Valve Replacement market looks promising in the next 5 years. As of 2022, the global Transcatheter Mitral Valve Replacement market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......
  • Global Thoracic Surgery Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 92
    Thoracic surgery is a procedure to treat medical conditions involving heart and lungs. It includes therapies such as redo heart surgery, aortic dissection for aortic surgery, minimally invasive mitral valve repair and replacement, and endovascular repair of thoracic aortic aneurysms. Market Analysis and Insights: Global Thoracic Surgery Market The global Thoracic Surgery market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth......
  • Global Angina Pectoris Treatment Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 29-Jun-2023        Price: US 3260 Onwards        Pages: 120
    The Angina Pectoris Treatment market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Angina Pectoris Treatment industry, and breaks down according to the type, application, and consumption area of Angina Pectoris Treatment. The report also introduces players in the industry from the perspective of the industry chain and marketing ......
  • Global Transcatheter Mitral Valve Replacement Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 15-Jun-2023        Price: US 3260 Onwards        Pages: 109
    The Transcatheter Mitral Valve Replacement market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Transcatheter Mitral Valve Replacement industry, and breaks down according to the type, application, and consumption area of Transcatheter Mitral Valve Replacement. The report also introduces players in the industry from the perspecti......
  • Global Angina Pectoris Treatment Market Size, Share and Industry Analysis by Regions, Countries, Types, and Applications, Forecast to 2028
    Published: 19-May-2023        Price: US 3480 Onwards        Pages: 105
    The global Angina Pectoris Treatment market size was valued at USD XX Million in 2022 and will reach USD XX Million in 2028, with a CAGR of XX% during 2022-2028. The Angina Pectoris Treatment market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types......
  • Global Thoracic Surgery Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-May-2023        Price: US 3260 Onwards        Pages: 100
    The Thoracic Surgery market revenue was 3777.06 Million USD in 2022, and will reach 4689.46 Million USD in 2028, with a CAGR of 3.67% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Thoracic Surgery industry, and breaks down according to the type, application, and consumption area of Thoracic Surgery. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and descr......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs